Marico bets on ₹1,012-cr Plix deal for ₹20,000-cr revenue goal

Marico has increased its stake in Satiya Nutraceuticals, the owner of the fintech brand Plix, to 84.09% through an acquisition worth ₹1,012 crore. This strategic move is part of Marico's broader plan to diversify its business model beyond traditional FMCG and tap into the growing digital lending space.
For investors, this deal signals a significant shift in Marico's growth strategy. By integrating Plix's digital-first approach, the company aims to leverage AI for better distribution and reach international markets. This move could help Marico reduce its reliance on traditional channels and create new revenue streams.
Moving forward, investors should watch how Marico integrates Plix into its existing operations. Key focus areas will include the company's ability to maintain profitability in the digital segment and its progress toward the ambitious ₹20,000 crore revenue target. The success of this digital push will be crucial for Marico's long-term growth story.
Excerpt from BusinessLine
Marico has raised its stake in Plix owner Satiya Nutraceuticals to 84.09% through a ₹1,012-crore acquisition as it pursues digital-first profitability, AI-led distribution and international diversification Marico has invested ₹1,012.03 crore to acquire an additional 24.09 per cent stake in Satiya Nutraceuticals, owner…Read the original at BusinessLine
Affected stocks
Bullish1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Marico (MARICO).
- Category: Orders & Deals.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Marico worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.













